Company intelligence / Profile preview

Brooksville Pharmaceuticals

Brooksville, Florida, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Brooksville Pharmaceuticals operates as a retail and compounding pharmacy, offering commercial and patient-specific customized formulations in hormone replacement, weight management (GLP-1 drugs), urology, and nutritional optimization. It has faced regulatory and legal scrutiny over compounding GLP-1 drugs, with recent court rulings impacting its ability to mass-produce certain dosages. No clinical trial pipeline.

Therapeutic areas: Men's HealthEndocrinologyMetabolic Disorders
Modalities: Small moleculeBiologic (compounded hormones)Peptides (compounded retatrutide, semaglutide)
Industry: Non-Academic Healthcare

Partnerships

None publicly disclosed; collaborates with clinics for patient/caregiver service

Beyond the preview

Go deeper on Brooksville Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brooksville Pharmaceuticals.

Explore the full profile